Aptorum Group is a Hong Kong-based life science and biopharmaceutical company dedicated to acquiring, developing and commercializing novel biopharmaceutical products and innovations around the world.
By collaborating with the world’s leading universities and scientific institutions, Aptorum actively seeks product candidates which tackle key global health challenges and address unmet medical needs. Also, by leveraging their business network and efficient management, Aptorum facilitates our portfolio companies to unleash their life science development capabilities that propel innovative solutions for healthcare advancement.
As of December 2017, Aptorum Group has obtained 11 exclusive licenses covering neurology, infectious diseases, gastroenterology, oncology, surgical robotics and natural health, etc.
Additionally, Aptorum is dedicating resources to develop a worldwide medical clinics network (commencing in Hong Kong initially), which assembled with talented clinicians and surgical experts, to address the demand for high quality healthcare services in the region.
17/F, Guangdong Investment Tower
148 Connaught Road
Central, Hong Kong
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Class of 2018 Biotech IPOs Investor Day
Davis Polk Event Space,
April 26, 2019
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by